Tevogen Bio Holdings Management
Management criteria checks 1/4
Tevogen Bio Holdings' CEO is Ryan Saadi, appointed in Feb 2024, has a tenure of less than a year. total yearly compensation is $501.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 71.19% of the company’s shares, worth €69.66M. The average tenure of the management team and the board of directors is 0.5 years and 1.5 years respectively.
Key information
Ryan Saadi
Chief executive officer
US$501.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | less than a year |
| CEO ownership | 71.2% |
| Management average tenure | less than a year |
| Board average tenure | 1.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$19m |
| Dec 31 2023 | US$501k | US$501k | -US$60m |
| Sep 30 2023 | n/a | n/a | -US$63m |
| Jun 30 2023 | n/a | n/a | -US$64m |
| Mar 31 2023 | n/a | n/a | -US$47m |
| Dec 31 2022 | US$454k | US$453k | -US$22m |
Compensation vs Market: Ryan's total compensation ($USD501.00K) is about average for companies of similar size in the German market ($USD530.63K).
Compensation vs Earnings: Ryan's compensation has increased whilst the company is unprofitable.
CEO
Ryan Saadi (59 yo)
less than a year
Tenure
US$501,000
Compensation
Dr. Ryan Saadi, M.D., M.P.H., has been Chief Executive Officer and Chairperson Tevogen Bio Holdings Inc. since February 14, 2024. He served as Chief Executive Officer and Chairperson of Tevogen Bio beginni...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | less than a year | US$501.00k | 71.19% $ 69.7m | |
| Chief Financial Officer | less than a year | US$300.00k | 5.84% $ 5.7m | |
| Chief Scientific Officer and Global R&D Lead | 2.1yrs | US$2.93m | 0% $ 0 | |
| Chief Technical Officer | 2.3yrs | no data | no data | |
| Chief Information Officer & Head of Tevogen.ai | less than a year | no data | no data | |
| Head of Investor Relations & Corporate Development | less than a year | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data |
0.5yrs
Average Tenure
64.5yo
Average Age
Experienced Management: G28's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | less than a year | US$501.00k | 71.19% $ 69.7m | |
| Member of Advisory Board | 2.6yrs | no data | 5.8% $ 5.7m | |
| Member of Advisory Board | 2.6yrs | no data | no data | |
| Independent Director | 1.1yrs | US$253.46k | 0% $ 0 | |
| Independent Director | 2yrs | no data | 0.12% $ 114.2k | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 2yrs | no data | 0% $ 0 | |
| Independent Director | less than a year | no data | 0.58% $ 571.2k | |
| Member of Advisory Board | 2.6yrs | no data | no data | |
| Member of Advisory Board | 2.2yrs | no data | no data | |
| Member of Advisory Board | less than a year | no data | no data | |
| Director | less than a year | no data | 5.52% $ 5.4m |
1.5yrs
Average Tenure
65.5yo
Average Age
Experienced Board: G28's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.